Startup event

Startup event

Reflecting on Slush 2024

Actimi Team

Nov 21, 2024

Nov 21, 2024

Nov 21, 2024

1

min.

Slush 2024
Slush 2024
Slush 2024
Slush 2024

This year we had the privilege of attending Slush again, perfectly timed to coincide with the first snowfall in Helsinki. Our primary goal was to showcase our API-first digital health platform to some of the 13,000 attendees from around the world.

Our focus was twofold:

To understand how startups and enterprises can scale their development efforts using our platform.

To gauge whether investors recognise this as a strategic advantage for their digital health startup portfolios.

Key insights from Slush

We observed a clear and growing demand for a certified development platform in the digital health space. One of the biggest challenges faced by European startups is achieving regulatory compliance, in particular obtaining a CE mark with MDR Class IIa certification. These certifications are often significant hurdles, slowing down healthcare software development to an average of six times slower than standard software.

With Actimi Signals set to receive its CE mark for MDR Class IIa certification this December, our platform becomes an invaluable tool for start-ups and established companies alike. It provides a compliant, robust foundation that reduces regulatory barriers and accelerates the development process. This positions our platform as a game changer for companies looking to innovate in a highly regulated industry.

Highlight: Developer SDK for rapid deployment

Designed for rapid and stable deployment, our Developer SDK was one of the most anticipated features launched at Slush. Fast and reliable deployment in a secure environment is critical to success in the digital health sector, and the enthusiastic response from attendees validated our approach.

We would like to thank the German Trade and Invest (GTAI) organisation for providing us with the platform to showcase our innovation. We also commend the Slush team for organising another exceptional event that remains unparalleled in its focus on founders and startups.

Looking ahead, we are more committed than ever to supporting digital health innovation with our API-first platform, bridging the gap between regulatory compliance and rapid development.

This year we had the privilege of attending Slush again, perfectly timed to coincide with the first snowfall in Helsinki. Our primary goal was to showcase our API-first digital health platform to some of the 13,000 attendees from around the world.

Our focus was twofold:

To understand how startups and enterprises can scale their development efforts using our platform.

To gauge whether investors recognise this as a strategic advantage for their digital health startup portfolios.

Key insights from Slush

We observed a clear and growing demand for a certified development platform in the digital health space. One of the biggest challenges faced by European startups is achieving regulatory compliance, in particular obtaining a CE mark with MDR Class IIa certification. These certifications are often significant hurdles, slowing down healthcare software development to an average of six times slower than standard software.

With Actimi Signals set to receive its CE mark for MDR Class IIa certification this December, our platform becomes an invaluable tool for start-ups and established companies alike. It provides a compliant, robust foundation that reduces regulatory barriers and accelerates the development process. This positions our platform as a game changer for companies looking to innovate in a highly regulated industry.

Highlight: Developer SDK for rapid deployment

Designed for rapid and stable deployment, our Developer SDK was one of the most anticipated features launched at Slush. Fast and reliable deployment in a secure environment is critical to success in the digital health sector, and the enthusiastic response from attendees validated our approach.

We would like to thank the German Trade and Invest (GTAI) organisation for providing us with the platform to showcase our innovation. We also commend the Slush team for organising another exceptional event that remains unparalleled in its focus on founders and startups.

Looking ahead, we are more committed than ever to supporting digital health innovation with our API-first platform, bridging the gap between regulatory compliance and rapid development.

This year we had the privilege of attending Slush again, perfectly timed to coincide with the first snowfall in Helsinki. Our primary goal was to showcase our API-first digital health platform to some of the 13,000 attendees from around the world.

Our focus was twofold:

To understand how startups and enterprises can scale their development efforts using our platform.

To gauge whether investors recognise this as a strategic advantage for their digital health startup portfolios.

Key insights from Slush

We observed a clear and growing demand for a certified development platform in the digital health space. One of the biggest challenges faced by European startups is achieving regulatory compliance, in particular obtaining a CE mark with MDR Class IIa certification. These certifications are often significant hurdles, slowing down healthcare software development to an average of six times slower than standard software.

With Actimi Signals set to receive its CE mark for MDR Class IIa certification this December, our platform becomes an invaluable tool for start-ups and established companies alike. It provides a compliant, robust foundation that reduces regulatory barriers and accelerates the development process. This positions our platform as a game changer for companies looking to innovate in a highly regulated industry.

Highlight: Developer SDK for rapid deployment

Designed for rapid and stable deployment, our Developer SDK was one of the most anticipated features launched at Slush. Fast and reliable deployment in a secure environment is critical to success in the digital health sector, and the enthusiastic response from attendees validated our approach.

We would like to thank the German Trade and Invest (GTAI) organisation for providing us with the platform to showcase our innovation. We also commend the Slush team for organising another exceptional event that remains unparalleled in its focus on founders and startups.

Looking ahead, we are more committed than ever to supporting digital health innovation with our API-first platform, bridging the gap between regulatory compliance and rapid development.

Updated date:

Nov 21, 2024

More posts

ACTIMI at the E-Health Congress 2025 in Augsburg
ACTIMI at the E-Health Congress 2025 in Augsburg

Event

Event

ACTIMI at the E-Health Congress 2025 in Augsburg

May 26, 2025

Enabling Scalable Telemedicine: How Actimi Utilizes HL7 FHIR for Seamless Interoperability
Enabling Scalable Telemedicine: How Actimi Utilizes HL7 FHIR for Seamless Interoperability

Interoperability

Interoperability

Enabling Scalable Telemedicine: How Actimi Utilizes HL7 FHIR for Seamless Interoperability

May 9, 2025

G-BA Reimbursement Policy for Telemonitoring in Heart Failure: Seizing Opportunities, Shaping the Future
G-BA Reimbursement Policy for Telemonitoring in Heart Failure: Seizing Opportunities, Shaping the Future

Telemonitoring

Telemonitoring

G-BA Reimbursement Policy for Telemonitoring in Heart Failure: Seizing Opportunities, Shaping the Future

May 2, 2025

Medica Pitch

Event

Review on MEDICA 2024

November 18, 2024

ACTIMI at the E-Health Congress 2025 in Augsburg

Event

ACTIMI at the E-Health Congress 2025 in Augsburg

May 26, 2025

Enabling Scalable Telemedicine: How Actimi Utilizes HL7 FHIR for Seamless Interoperability

Interoperability

Enabling Scalable Telemedicine: How Actimi Utilizes HL7 FHIR for Seamless Interoperability

May 9, 2025